Inhibition of nuclear factor κB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons

European Journal of Pharmacology

Volumn 547, Issue 1-3, 2006, Pages 10-21

  Cherng, Jaw Ming ^a   Lin, Hsiang Ju ^b   Hung, Man Shan ^c   Lin, Yi Ruu ^c   Chan, Ming Huan ^c   Lin, Jung Chung ^c  

^a I SHOU UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Ca2+ influx; Glutamate; Glycyrrhizic acid; Neuronal apoptosis; Neuroprotection; NMDA receptor; Transcription factor

Indexed keywords

DNA FRAGMENT; GLUTAMIC ACID; GLYCYRRHIZIC ACID; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN DAMAGE; CALCIUM TRANSPORT; CELL SURVIVAL; CONCENTRATION RESPONSE; ENZYME INHIBITION; EXCITOTOXICITY; FEMALE; GEL MOBILITY SHIFT ASSAY; HIPPOCAMPUS; INHIBITION KINETICS; MEMBRANE DEPOLARIZATION; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALCIUM; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GLUTAMIC ACID; GLYCYRRHIZIC ACID; MEMBRANE POTENTIALS; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TETRODOTOXIN;

EID: 33748531846     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.080     Document Type: Article

References (46)

1. Abe M., Akbar S.M.F., Hasebe A., Horiike N., and Onji M. Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis. J. Gastroenterol. 38 (2003) 962-967
2. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19 (1991) 2499
3. Armanini D., Fiore C., Mattarello M.J., Bielenberg J., and Palermo M. History of the endocrine effects of licorice. Exp. Clin. Endocrinol. Diabetes 110 (2002) 257-261
4. Baldwin A.S. The NF-kB and IkB proteins: new discoveries and insights. Annu Rev. Immunol. 14 (1996) 649-681
5. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kB. J. Clin. Invest. 107 (2001) 241-246
6. Bean P. The use of alternative medicines in the treatment of hepatitis C. Am. Clin. Lab. 21 (2002) 19-21
7. Beg A.A., and Baldwin A.S. The IkB proteins: multifunctional regulators of Rel/NF-kB transcription factors. Genes Dev. 7 (1993) 2064-2070
8. Beg A.A., Finco T.S., Nantermet P.V., and Baldwin A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IkBα: a mechanism for NF-kB activation. Mol. Cell. Biol. 13 (1993) 3301-3310
9. Briolant S., Garin D., Scaramozzino N., Jouan A., and Crance J.M. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antivir. Res. 61 (2004) 111-117
10. 1-induced cytotoxicity in hepatoma cells. Toxicology 188 (2003) 211-217
11. Cherng J.-M., Lin H.-J., Hsu Y.-H., Hung M.-S., and Lin J.-C. A quantitative bioassay for HIV-1 gene expression based on UV-activation: effect of glycyrrhizic acid. Antivir. Res. 62 (2004) 27-36
12. Cinatl J., Morgenstem B., Bauer G., Chandra P., Rabenau H., and Doerr H.W. Glycyrrhizin, and active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361 (2003) 2045-2046
13. Cinatl J., Michaelis M., Hoever G., Preiser W., and Doerr H.W. Development of antiviral therapy for severe acute respiratory syndrome. Antivir. Res. 66 (2005) 81-97
14. Coon J.T., and Ernst E. Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review. J. Hepatol. 40 (2004) 491-500
15. Coulter D.A., and DeLorenzo R.J. Basic mechanisms of status epilepticus. Adv. Neurol. 79 (1999) 725-733
16. Crance J.M., Scaramozzino N., Jouan A., and Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antivir. Res. 58 (2003) 73-79
17. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22 (1999) 391-397
18. Fiore C., Salvi M., Palermo M., Sinigaglia G., Armanini D., and Toninello A. On the mechanism of mitochondrial permeability transition induction by glycyrrhetinic acid. Biochim. Biophys. Acta 1658 (2004) 195-201
19. Fujisawa Y., Sakamoto M., Matsushita M., Fujita T., and Nishioka K. Glycyrrhizin inhibits the lytic pathway of complement-possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis. Microbiol. Immunol. 44 (2000) 799-804
20. Grilli M., Pizzi M., Memo M., and Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kB activation. Science 274 (1996) 1383-1385
21. Grimm S., Bauer M.K.A., Baeuerle P.A., and Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell Biol. 134 (1996) 13-23
22. Gumpricht E., Dahl R., Devereaux M.W., and Sokol R.J. Licorice compounds glycyrrhizin and 18β-glycyrrhetinic acid are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes. J. Biol. Chem. 280 (2005) 10556-10563
23. Hibasami H., Iwase H., Yoshioka K., and Takahashi H. Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells. Int. J. Mol. Med. 17 (2006) 215-219
24. Kaltschmidt C., Kaltschmidt B., and Baeuerle P.A. Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9618-9622
25. Kawakami F., Shimoyama Y., and Ohtsuki K. Characterization of complement C3 as a glycyrrhizin (GL)-binding protein and the phosphorylation of C3α by CK-2, which is potently inhibited by GL and glycyrrhetinic acid in vitro. J. Biochem. 133 (2003) 231-237
26. Kinjo J., Hirakawa T., Tsuchihashi R., Nagao T., Okawa M., Nohara T., and Okabe H. Hepatoprotective constitutes in plants 14. Effects of soyasapogenol B, sophoradiol, and their glucuronides on the cytotoxicity of tert-butyl hydroperoxide to HepG2 cells. Biol. Pharm. Bull. 26 (2003) 1357-1360
27. Kopp E., and Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265 (1994) 956-959
28. La Rosa F.A., Pierce J.W., and Sonenshein G.E. Differential regulation of the c-myc oncogene promoter by the NF-κB Rel family of transcription factors. Mol. Cell. Biol. 14 (1994) 1039-1044
29. Lin .J.-C. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antivir. Res. 59 (2003) 41-47
30. Malenka R.C., and Nicoll R.A. Long-term potentiation - a decade of progress. Science 285 (1999) 1870-1874 (226, 98-104)
31. McGeer E.G., and McGeer P.L. Inflammatory processes in Alzheimer's disease. Prog. Neuro-psychopharmacol. Biol. Psych. 27 (2003) 741-749
32. Obeid L.M., Linardic C.M., Karolak L.A., and Hannun Y.A. Programmed cell death induced by ceramide. Science (Wash. D.C.) 259 (1993) 1769-1771
33. Osborn L., Kunkel S., and Nabel G.J. Tumor necrosis factor alpha and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2336-2340
34. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as factor and HIV-1. EMBO J. 10 (1991) 2247-2258
35. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., and Schwaninger M. NF-kappa B is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5 (1999) 554-559
36. Schulze-Osthoff K., Krammer P.H., and Droge W. Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13 (1994) 4587-4596
37. Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 120 (2000) 849-862
38. Sun S.C., Ganchi P.A., Ballard D.W., and Greene W.C. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science (Wash. D.C.) 259 (1993) 1912-1915
39. 32β, a mammalian homolog to CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81 (1995) 801-809
40. Van Rossum T.G., Vulto A.G., Hop W.C., Brouwer J.T., Niesters H.G., and Schalm S.W. Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial. J. Gastroenterol. Hepatol. 14 (1999) 1093-1099
41. Wang Z.-Q., Stingl L., Morrison C., Jantsch M., Los M., Schulze-Osthoff K., and Wagner E.F. PARP is important for genomic stability but dispensable in apoptosis. Gene Dev. 11 (1997) 2347-2358
42. Weber J.T., Rzigalimski B.A., Willoughby K.A., Moore S.F., and Ellis E.F. Alteration in calcium-mediated signal transduction after traumatic injury of cortical neurons. Cell Calcium 26 (1999) 289-299
43. Winter B.D., and Bussey T.J. Glutamate receptors in perirhinal cortex mediate encoding, retrieval, and consolidation of object recognition memory. J. Neurobiol. 25 (2005) 4243-4251
44. Wu H., and Lozano G. NF-κB activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269 (1994) 20067-20074
45. Yamamoto Y., and Gaynor R.B. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107 (2001) 135-142
46. Zheng Q.-Z., and Lou Y.-J. Pathologic characteristics of immunologic injury in primary cultured rat hepatocytes and protective effect of glycyrrhizin in vitro. Acta Pharmacol. Sin. 24 (2003) 771-777